At molecular level, ANXA3 silencing in pancreatic cancer cells resulted in a decrement of the expression of vascular endothelial growth factor receptor 3 (VEGFR3), which is a protein suggested to play a key role in lymphatic vascularization in pancreatic cancer (Wan et al., 2020). Here, FLT4 is linked to pancreatic neoplasm.